Keagan S. Casey

681 total citations
4 papers, 24 citations indexed

About

Keagan S. Casey is a scholar working on Oncology, Physiology and Immunology. According to data from OpenAlex, Keagan S. Casey has authored 4 papers receiving a total of 24 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Physiology and 2 papers in Immunology. Recurrent topics in Keagan S. Casey's work include CAR-T cell therapy research (4 papers), Biosimilars and Bioanalytical Methods (2 papers) and Biomedical Ethics and Regulation (2 papers). Keagan S. Casey is often cited by papers focused on CAR-T cell therapy research (4 papers), Biosimilars and Bioanalytical Methods (2 papers) and Biomedical Ethics and Regulation (2 papers). Keagan S. Casey collaborates with scholars based in United States and United Kingdom. Keagan S. Casey's co-authors include Kathleen Gallagher, Marcela V. Maus, Matthew J. Frigault, Heather Daley, Jami Brown, Myriam Armant, Lu Huang, Thomas R. Spitzer, Sarah Nikiforow and Daniella Cook and has published in prestigious journals such as Blood, Journal of the American Society of Nephrology and Cytometry Part B Clinical Cytometry.

In The Last Decade

Keagan S. Casey

3 papers receiving 24 citations

Peers

Keagan S. Casey

ONCOL

GENET

IMMUN

BE

MB

Lifang Huang China

Lisa Frölich Germany

Tiarlan Sirait France

Joanne Shea United States

Kristen E. Rigolizzo United States

Svetlana Balandraud France

Shuixiu Peng China

Arianne Perez United States

Marcela Martínez-Prieto United States

Sandra Karitzky Germany

Lifang Huang China

Keagan S. Casey

26 ×1.1

ONCOL

10 ×0.9

GENET

5 ×0.7

IMMUN

2 ×0.3

BE

4 ×1.0

MB

Citations per year, relative to Keagan S. Casey Keagan S. Casey (= 1×) peers Lifang Huang

Countries citing papers authored by Keagan S. Casey

Since Specialization

Citations

This map shows the geographic impact of Keagan S. Casey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keagan S. Casey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keagan S. Casey more than expected).

Fields of papers citing papers by Keagan S. Casey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keagan S. Casey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keagan S. Casey. The network helps show where Keagan S. Casey may publish in the future.

Co-authorship network of co-authors of Keagan S. Casey

This figure shows the co-authorship network connecting the top 25 collaborators of Keagan S. Casey. A scholar is included among the top collaborators of Keagan S. Casey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keagan S. Casey. Keagan S. Casey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Johansson, Ulrika, Kathleen Gallagher, Marcela V. Maus, et al.. (2021). Detection of CAR‐T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories. Cytometry Part B Clinical Cytometry. 100(6). 622–631. 3 indexed citations

2.

Frigault, Matthew J., Yi‐Bin Chen, Kathleen Gallagher, et al.. (2021). Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies. Blood. 138(Supplement 1). 653–653. 11 indexed citations

3.

Frigault, Matthew J., Kathleen Gallagher, Marc Wehrli, et al.. (2021). A Phase II Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity. Blood. 138(Supplement 1). 2814–2814. 10 indexed citations

4.

Lee, Meghan, Ian A. Strohbehn, Harish Seethapathy, et al.. (2020). Clinical Features of AKI in Patients Receiving Tisagenlecleucel (CAR-T Therapy). Journal of the American Society of Nephrology. 31(10S). 664–664.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact